Sierra Oncology, Inc.
SRRADelisted Jul 1, 2022- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001290149
Sierra Oncology, Inc. was delisted on Jul 1, 2022; its insiders filed their last Form 4 on Jul 1, 2022; 109 institutions reported holding it in 13F filings for Q2 2022, worth $1.23B in total; no superinvestor held it.
Q2 2021 vs. Q1 2021
How the institutions holding Sierra Oncology, Inc. changed between Q1 2021 and Q2 2021.
All holders in Q2 2021All holders in Q1 2021
| Measure | Q1 2021 | Q2 2021 | Change |
|---|---|---|---|
| Holders | 33 | 34 | +1 |
| Shares | 8.70M | 9.03M | +329.6K (+3.8%) |
| Value | $149.7M | $171.8M | +$22.2M (+14.8%) |
New holders (3)
Institutions that held Sierra Oncology, Inc. at the end of Q2 2021 but not at the end of Q1 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Nan Fung Group Holdings Ltd | 130,979 | $2.55M | 0.79% |
| Sofinnova Investments, Inc. | 2,500 | $49.0K | 0.00% |
| Strategic Blueprint, LLC | 782 | $15.0K | 0.00% |
Sold out (2)
Institutions that held Sierra Oncology, Inc. at the end of Q1 2021 and filed for Q2 2021 without it.
| Institution | Shares, Q1 2021 | Value, Q1 2021 |
|---|---|---|
| Sowell Financial Services LLC | 871 | $16.0K |
| Tower Research Capital LLC (TRC) | 388 | $7.00K |